{"name":"Tavanta Therapeutics","slug":"tavanta-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxOcDRRemVpZUZMdFFFcWVuSnh1T2ZYbllXYmJLVEZpMHVnX0FtcEQwQUd4NmUwNTcxMjRfZVVnYVY2anRMRVRMY1dQWVFVSmk0Z2xqN3lrdEhlODNLQXRadDRRSHJTQzY0M09wSVdSc0M4NHpueVZlM2hnLWs2RXZJWjJhSS14eGdsM0tNVGw2ZnE3bEpnbXJBS0ZWU01LaHhvM3JjXzFCVzB4UEE4QUdGT05aMXhadVAyWDNjNUJJT2ZQU21MOFNlRXJCeXNtXzFFRlpHWGJTN2oyaFpzX294cjB0YXMtQmU4NEp2MTJ5T1JsUWU3ZlJZQV9PWnJLUkd0emlaNGxpQ1p4VER1Q3daaHN3djVEbzFJMVh2WVhFd2NMYzNLUHRjUXNkOGtmX2dtY0c1TFEtQ1VlREUwWlVncllvU3pQYmxvMmJHdXlaVQ?oc=5","date":"2026-04-03","type":"trial","source":"Barchart.com","summary":"Metastatic Prostate Cancer Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Curium, Merck/ Orion, Pfizer, AstraZeneca, Telix Pharma, Tavanta - ","headline":"Metastatic Prostate Cancer Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by De","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNYjF5N2lVbjNNdlgxT2R3ZzZ1SVBlMnpyX1pnZUswLUVMRGRZMEt4Y0NJS2ZJX3dRRmZXSW9mMGp2UzljczN6UEdxQ0NGYTR2bVYydkQ5SzVxLUtfNmFhWG9vQlhER2ZDRXYyaHJZZFdTQmtZZWpSdGdOc3dtYVdyMUh1d2UydFB2WkdQeG5oeDZrb1ZEb0hOLWdacVZfeDZjbmE1OW1pMkp0OU13M05abHVfUUI5SmZJdV9uaTNwV2RCeURoSk1ScU5UVU9JZVZFWnlNUFc2ekJHN3ZaaHZFZlF5a21iZ3RyYkE2bTVwVmZIVGZPUDNZYUVvang?oc=5","date":"2026-02-11","type":"regulatory","source":"The Malaysian Reserve","summary":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight - The Malaysian Reserve","headline":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOaWJHTkVvd3diWm9pX3c0aEx4MnZfMmRmRkczT3g4ZkE1RmE4eU1Qd1JmSXBsVThCYUlib0dLNEt1M0tVOHlZNnBodFpuRngxM2kyOFBkOUlENlB6bUx4Q2NqUmY4ek02SmtlT1h6ZUQ0M29nYzJtVkNUTC01aEpyUkN5VXBSV3U4aDczQ0NqMVFWRjcwTHd4ejdFT3ZLTjNtaWdhT3pKNkYtWlY1REJaUEk0VWN4UjdLaWg5NFhtbkhqUXJCekhoWnB1RG5FTFRpOEttc1RwLVY1VGdQSlB6M2hlcC1KTENhSC01WWRtNXh4NnVCNDN3YkJTZURpOTg?oc=5","date":"2026-01-20","type":"pipeline","source":"prnewswire.com","summary":"PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight - prnewswire.com","headline":"PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxPcG02MzkwN3FNRFZGZnFTVEZWUXpIaUtiYVBNMlFkVEVOLS1OTVhhcWVUM284VkR1T0FNQkNWM2hxWE9HUXlmX1ZUTTBsRWZpOFlGVVExT19vMy0tX2hPRXRaX3FoMEQ5MFR5MEx2TVBIYV9DeUw1Q21FVzBYcWpNdXFMRkZtTWxuNjl3ZlE4VEZhYklIV295alFMeml3RzF4WlEzX0RkdHNTdkV3eG9sUGFUYjVtenlIR1VnV1RCQ293blNONVhnUGRBY3c4bFpsdW5WZzFWeEdoM0QxN2gwZmxnTmRkanBmU2VZNE43cVRveDlWVW5hekNnV3NvZWpjbnlxYjFYRVh4dkpWLVFHeU9sNEZkdVJ5eUZWRWF6TFhqV3N4a054V3VnZEY1aGx2UmFwVEpkZEZoVy1QNklnWVo2X2hCc2lydjhYVHotS0VyT3I0ZVgwcnRkaUg0dGxZ?oc=5","date":"2026-01-05","type":"regulatory","source":"PR Newswire UK","summary":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight - PR New","headline":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval a","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVXR3X1llcjZvcTktdnduWjhoZ1NRMUpCVGs4Qy14cXljSm92MUVTajNnX2g1S0ZwbjZJVFNaTWRtNTVMUG9lNW56cnZoMm54a190eklkak9hT2ZpWDVDeUJzRU91Z3otSXFEY1Nub0VrQ1BZZ2p5UmwzSGtxQldQb3p2Q1gwUmszSDFkdnJOYUdESUZPZ21aOHpqa3lVS05vVF81Wk01OE1XSUpqRmhjMDJId1JoVHFUS0ZNT05aWl85RVAzcnRNU1hXRTM2VWRqWlZtNE1BY1V6b2F5a2N3WGs2STFvNUxlalBv?oc=5","date":"2025-08-07","type":"pipeline","source":"PR Newswire UK","summary":"FAP Inhibitors Market Analysis Across the 7MM: Key Insights and Outlook Through 2040 | DelveInsight - PR Newswire UK","headline":"FAP Inhibitors Market Analysis Across the 7MM: Key Insights and Outlook Through 2040 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Metastatic Castration-Resistant Prostate Cancer Market to - GlobeNewswire","headline":"Metastatic Castration-Resistant Prostate Cancer Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNYWZIR1FURDU4dFFXaEs3bjFkYk4zOERRa25WempmaDRMcndkNEtQTV81NTlUWWdONjNxLVdrNmlfMHBRZVU1a055NlhFLTVQcEs0LTNFWktRZDR1RHVtVjRIMzBuMVZuUFhDa01WT3lKaTY4ckZQRjFlSnc2YzNjTjhRbU5yYjN3NC1pSU1ZYTM3b1pVRjhyVVRxMGxRbFpmcUtoQ0VDTlY3VTJySExPM0t3a1JhU3pWUGROWV9yTmNHLXZ4UUZybzdDYS05R3lwRFozaGJHTkNFVjRTV0dfb2U5VDNEODhBaDdNTmJNNl9FUzJKT29ZV016Ynk0VTZjdjQ2S3NDV3paeVpWNDFUN2IzaFpKd0RZc21mSlZwTXhxeUVnNTRuQ0hQQ0pGamZTT1M5ZjNXZ1lGdU0zbzcteXdUWQ?oc=5","date":"2024-10-15","type":"trial","source":"GlobeNewswire","summary":"Prostate Cancer Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"Prostate Cancer Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQZ0J2QXItYWRWN1NOWHQ1RVZ5TmtTYkFZZTBOdGFwYzZNMUJiOEJUZ0l3MGNXN0tXcERsck5pZnpFZldiTEJVeVBoaUNiN3RjUUZ5VVFoTW5RSG5LT3ZPcHJCQkxkcTNFLTRxUEFTU2twei15Ym1JSTZLTXA3bGwyTXlHUmZIMnNWLXhMR3lieENIekVzbUE0YXVOaGdHWnZPLWZ3ZExHZER5dC04bkJWU1gxNHRxZFlGM2ZWeHFDMmhGdE85Q2JnZjdJdUdlQ0p0UW41Vm1uVjlZTjkyNW1wRk9JRGdsUzhUMlQtQi1yNFZ4U0VOMEVlZ3NHa3dUY0lBSFgyS2s5emVqSG1yb3dZS3JfbnlxVGljTUxBNmVNRTQwM1A1SWc?oc=5","date":"2020-09-01","type":"pipeline","source":"prnewswire.com","summary":"Tavanta Therapeutics, New Specialty Pharmaceutical Company, Has Diverse Pipeline of Novel Drugs and Risk-Balanced Approach to Product Development - prnewswire.com","headline":"Tavanta Therapeutics, New Specialty Pharmaceutical Company, Has Diverse Pipeline of Novel Drugs and Risk-Balanced Approa","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}